Clinical Trial Update: Argatroban for Preventing Occlusion and Restenosis After Extracranial Vertebral Artery Stenting [Phase 4]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 4 study evaluating argatroban to prevent occlusion and restenosis after extracranial vertebral arte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Argatroban (argatroban)

Snippet

Sponsor: Xinfeng Liu | Conditions: CVD | Phase 4 | Status: COMPLETED